化学科研者一站式服务平台


  • EMD-1214063; 3-[1,6-二氢-1-[[3-[5-[(1-甲基-4-哌啶基)甲氧基]-2-嘧啶基]苯基]甲基]-6-氧代-3-哒嗪基]苯腈

    3-[1-[[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxopyridazin-3-yl]benzonitrile

化合物简介

EMD 1214063 is a novel ATP-comptetitive inhibitor of the MET hepatocyte growth factor receptor and a novel kinase inhibitor and a therapeutic agent for neuroblastoma.

基本信息

CAS:1100598-32-0
中文别名
英文别名:3-(1-(3-(5-(1-methylpiperidin-4-ylmethoxy)pyrimidin-2-yl)benzyl)-1,6-dihydro-6-oxopyridazin-3-yl)benzonitrile;3-(1-{3-[5-(1-methylpiperidin-4-ylmethoxy)pyrimidin-2-yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile;
分子式:C29H28N6O2
分子量:492.572
精确质量:492.227
Psa:96.93
Logp:3.94578

编号系统

MDL号:MFCD18452823

物化性质

密度:1.3±0.1g/cm3
沸点:626.5±65.0°Cat760mmHg
闪点:332.7±34.3°C
外观性状:粉末
蒸汽压:0.0±1.8mmHgat25°C
折射率:1.660
储存条件:-20℃

安全信息

生产方法及用途

合成路线

上游原料

下游产品

图谱

13C NMR : Predict


加载中...